Moderna to Present at Upcoming Conferences in September 2025

Rhea-AI Summary

Moderna (NASDAQ:MRNA) has announced its participation in two major healthcare investor conferences in September 2025. The company will present at the Morgan Stanley's 23rd Annual Global Healthcare Conference on September 8th at 10:00am ET and at Bernstein Insights: Healthcare Leaders and Disruptors on September 25th at 10:30am ET.

Investors can access live webcasts of both presentations through the "Events and Presentations" section of Moderna's investor website. The webcasts will remain archived on the company's website for a minimum of 30 days after each presentation.

CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the following upcoming investor conferences:

Morgan Stanley's 23^rd Annual Global Healthcare Conference, on Monday, September 8^th at 10:00am ET

Bernstein Insights: Healthcare Leaders and Disruptors, on Thursday, September 25^th at 10:30am ET

A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.

investors.modernatx.com.

A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Media Contacts

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

FAQ

When is Moderna presenting at the Morgan Stanley Healthcare Conference 2025?

Moderna will present at Morgan Stanley's 23rd Annual Global Healthcare Conference on Monday, September 8th, 2025 at 10:00am ET.

When is Moderna's presentation at the Bernstein Insights conference?

Moderna will present at the Bernstein Insights: Healthcare Leaders and Disruptors conference on Thursday, September 25th, 2025 at 10:30am ET.

How can investors access Moderna's September 2025 conference presentations?

Investors can access live webcasts of the presentations through the 'Events and Presentations' section of Moderna's website at investors.modernatx.com.

How long will Moderna's conference webcasts be available for replay?

The webcasts will be archived on Moderna's website for at least 30 days following each presentation.